Name: Eculizumab
Brand: Samsung Bioepis
Availability: InStock

Thông tin cơ bản

880

4.4(18)

Danh mục

Nguyên liệu Dược phẩm (API)

Danh mục con & phụ

API Công nghệ sinh học / Kháng thể Đơn dòng

Loại giao dịch

Bán

Nhà sản xuất

Samsung Bioepis - Republic of Korea

Thông tin khác

Mô tả thêm:

South Korean biopharmaceutical company at Songdo in Incheon, founded in 2012 as a joint venture between Samsung Biologics and Biogen and wholly owned by Samsung Biologics since 2022. Develops and commercialises biosimilar medicines, with approved products referencing etanercept, infliximab, adalimumab, trastuzumab, bevacizumab, ranibizumab, aflibercept, ustekinumab and eculizumab among others, marketed worldwide through partners such as Organon and Biogen, and also works on novel biologics.